PTGS2 and Hepatic fibrosis: Previous studies indicated that COX2 activation with the subsequent PGs release favors the development of the necroinflammatory condition, HSCs proliferation, and angiogenesis that could contribute to hepatic fibrosis and carcinogenesis [53].